Skip to main content
. 2022 Feb 2;58(2):228. doi: 10.3390/medicina58020228

Figure 2.

Figure 2

Serum TNF-α (A), IL-17 (B), IL-10 (C), and IL-4 (D) levels in different groups of patients with osteoarthritis (control and after taking placebo for 3 months and Arthrocen for 3 and 6 months) measured by ELISA. Data were presented as Mean ± S.E.M., N = 25. * Significant difference at P < 0.05 in comparison to the control and placebo groups according to per t-test.